| Platelet phenotype analysis of COVID-19 patients reveals progressive changes in the activation of integrin αIIbβ3, F13A1, the SARS-CoV-2 Target EIF4A1 and Annexin A5 H Ercan, WC Schrottmaier, A Pirabe, A Schmuckenschlager, D Pereyra, ... Frontiers in cardiovascular medicine 8, 779073, 2021 | 27 | 2021 |
| Altered platelet proteome in lupus anticoagulant (LA)-positive patients—protein disulfide isomerase and NETosis as new players in LA-related thrombosis L Hell, K Lurger, LM Mauracher, E Grilz, CM Reumiller, GJ Schmidt, ... Experimental & molecular medicine 52 (1), 66-78, 2020 | 20 | 2020 |
| Alterations of the platelet proteome in lung cancer: accelerated F13A1 and ER processing as new actors in hypercoagulability H Ercan, LM Mauracher, E Grilz, L Hell, R Hellinger, JA Schmid, F Moik, ... Cancers 13 (9), 2260, 2021 | 19 | 2021 |
| Comparative proteomics reveals unexpected quantitative phosphorylation differences linked to platelet activation state GJ Schmidt, CM Reumiller, H Ercan, U Resch, E Butt, S Heber, ... Scientific Reports 9 (1), 19009, 2019 | 15 | 2019 |
| A practical and analytical comparative study of gel-based top-down and gel-free bottom-up proteomics including unbiased proteoform detection H Ercan, U Resch, F Hsu, G Mitulovic, A Bileck, C Gerner, JW Yang, ... Cells 12 (5), 747, 2023 | 11 | 2023 |
| Accelerated endoplasmic reticulum and coagulation factor processing in platelets are linked with the hypercoagulable state of patients with lung cancer H Ercan, LM Mauracher, E Grilz, L Hell, R Hellinger, JA Schmid, F Moik, ... | | 2021 |
| MASTERARBEIT/MASTER’S THESIS H Ercan | | 2019 |
| Differences in the platelet proteome between patients with cancer at high risk of venous thromboembolism and healthy controls LM Mauracher, H Ercan, E Grilz, L Hell, C Ay, I Pabinger, M Zellner Thrombosis Research 164, S181, 2018 | | 2018 |
